Premise, promise and challenges of MDMA assisted therapy for PTSD

Eur Neuropsychopharmacol. 2023 May:70:19-20. doi: 10.1016/j.euroneuro.2023.02.002. Epub 2023 Feb 15.

Authors

Santiago Madero¹, Oscar D Alvarez²

Affiliations

¹ University Hospital Clinic of Barcelona, Psychiatry and Psychology Department, Bipolar and Depressive Disorders Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain. Electronic address: madero@clinic.cat.
² Parc Sanitari Sant Joan de Deu Hospital, Sant Joan de Deu Research Foundation, Spain.

No abstract available

MeSH terms

Combined Modality Therapy
Hallucinogens* / therapeutic use
Humans
N-Methyl-3,4-methylenedioxyamphetamine* / therapeutic use
Psychotherapy
Stress Disorders, Post-Traumatic* / drug therapy

Substances

N-Methyl-3,4-methylenedioxyamphetamine
Hallucinogens